scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Caroline Day | |
P2860 | cites work | Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study. | Q51479700 |
The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. | Q51482560 | ||
An evaluation of the International Diabetes Federation definition of metabolic syndrome in Chinese patients older than 30 years and diagnosed with type 2 diabetes mellitus. | Q51494825 | ||
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. | Q51610700 | ||
Development of age-specific adolescent metabolic syndrome criteria that are linked to the Adult Treatment Panel III and International Diabetes Federation criteria. | Q53241303 | ||
Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. | Q53248709 | ||
Prevalence of the metabolic syndrome among Korean adults according to the criteria of the International Diabetes Federation. | Q53258018 | ||
Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young | Q53937437 | ||
Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?: Ischemic heart disease risk in the Singapore Cardiovascular Cohort Study | Q57502538 | ||
The Impact of Central Obesity as a Prerequisite for the Diagnosis of Metabolic Syndrome* | Q57502562 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey | Q29614468 | ||
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q33989576 | ||
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome | Q34116177 | ||
Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies | Q34574433 | ||
The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. | Q35135723 | ||
The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals | Q35781463 | ||
The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes | Q36218262 | ||
Insulin resistance--a common link between type 2 diabetes and cardiovascular disease | Q36458543 | ||
The insulin resistance syndrome: physiological considerations | Q36806509 | ||
Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition | Q39734387 | ||
Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population | Q39752727 | ||
Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease ? chicken, egg or neither? | Q40174964 | ||
Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis | Q40495289 | ||
Immunoassay of insulin with insulin-antibody precipitate | Q42961363 | ||
Predictive Properties of Impaired Glucose Tolerance for Cardiovascular Risk Are Not Explained by the Development of Overt Diabetes During Follow-Up | Q44187043 | ||
Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. | Q44470244 | ||
Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies | Q44527080 | ||
Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study | Q44779338 | ||
Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual | Q45034127 | ||
Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions | Q45118545 | ||
Obesity, regional body fat distribution, and the metabolic syndrome in older men and women | Q46433125 | ||
Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians. | Q46545819 | ||
The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions | Q46637307 | ||
Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions | Q46722365 | ||
Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study | Q46868484 | ||
Metabolic syndrome by the international diabetes federation definition in Hong Kong Chinese | Q46889306 | ||
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. | Q46966762 | ||
Performance of an NIDDM screening questionnaire based on symptoms and risk factors. | Q50963000 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metabolic syndrome | Q657193 |
P304 | page(s) | 32-38 | |
P577 | publication date | 2007-03-01 | |
P1433 | published in | Diabetes and Vascular Disease Research | Q5270121 |
P1476 | title | Metabolic syndrome, or What you will: definitions and epidemiology | |
P478 | volume | 4 |
Q94464762 | 3-Amino-1,2,4-Triazole Induces Quick and Strong Fat Loss in Mice with High Fat-Induced Metabolic Syndrome |
Q34694696 | A comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and system |
Q46507278 | A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy |
Q37192486 | A novel mathematical model detecting early individual changes of insulin resistance |
Q34058368 | Age at menarche and its association with the metabolic syndrome and its components: results from the KORA F4 study |
Q37193640 | Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study |
Q40067661 | All-cause and cardiovascular mortality risk estimation using different definitions of metabolic syndrome in Lithuanian urban population |
Q34059792 | Analysis of multiple phenotypes |
Q60046980 | Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review |
Q59126584 | Are non-high-density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study |
Q36522670 | Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat |
Q37105241 | Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study |
Q90246131 | Association of Dietary Patterns with Metabolic Syndrome: Results from the Kardiovize Brno 2030 Study |
Q42281087 | Association of meal frequency with metabolic syndrome in Korean adults: from the Korea National Health and Nutrition Examination Survey (KNHANES). |
Q36421188 | Autoimmune thyroid disease in rheumatoid arthritis: a global perspective |
Q33578721 | Behind and beyond the pediatric metabolic syndrome |
Q36812792 | Blood pressure normalization by fixed perindopril/indapamide combination in hypertensive patients with or without associate metabolic syndrome: results of the OPTIMAX 2 study |
Q50104362 | Body Mass Index and Acute Ischemic Stroke Outcomes |
Q46916215 | Can prolonged administration of valproic acid put patients with epilepsy at higher risk for development of Alzheimer's disease? |
Q50707024 | Cardiometabolic risk among Saudi children and adolescents: Saudi childrens overweight, obesity, and lifestyles (S.Ch.O.O.Ls) study. |
Q46296977 | Chronic social stress during adolescence in mice alters fat distribution in late life: prevention by antidepressant treatment |
Q36241377 | Comparison Study of Metabolic Syndrome's Differences and Diagnostic Criteria's Applicability among Xingjiang Uighur, Kazak and Han Population |
Q37626591 | Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population. |
Q43256494 | Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer |
Q37847244 | Current understanding of increased insulin sensitivity after exercise - emerging candidates. |
Q47375228 | Di-(2-ethylhexyl)-phthalate induces glucose metabolic disorder in adolescent rats |
Q27010200 | Diabetes, insulin resistance, and metabolic syndrome in horses |
Q55404051 | Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs. |
Q51434807 | Early cardiac dysfunction is rescued by upregulation of SERCA2a pump activity in a rat model of metabolic syndrome. |
Q41616248 | Early developmental exposure to high fructose intake in rats with NaCl stimulation causes cardiac damage. |
Q93016323 | Early evaluation of the metabolic syndrome in Bucaramanga, Colombia |
Q37452687 | Effects of caloric restriction on cardiovascular aging in non-human primates and humans |
Q33690934 | Effects of yam dioscorin interventions on improvements of the metabolic syndrome in high-fat diet-induced obese rats |
Q36986975 | Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial |
Q30248414 | Epidemiology of the locomotive syndrome: The research on osteoarthritis/osteoporosis against disability study 2005-2015. |
Q37078521 | Epidemiology, risk factors, and the promotion of pancreatic cancer: role of the stellate cell |
Q34099229 | Estimation of insulin resistance in non-diabetic normotensive Saudi adults by QUICKI, HOMA-IR and modified QUICKI: a comparative study. |
Q51580276 | Evaluation of anthropometric indices for metabolic syndrome in Chinese adults aged 40 years and over. |
Q34627551 | Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a Northern European family population |
Q36402230 | Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist. |
Q35671305 | GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis |
Q34057144 | Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome |
Q46352521 | Glycosylated hemoglobin and prevalent metabolic syndrome in nondiabetic multiethnic U.S. adults |
Q37678520 | Gonadal dysfunction in morbidly obese adolescent girls |
Q38831748 | Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage |
Q37385840 | Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy. |
Q37635741 | Improved insulin sensitivity after exercise: focus on insulin signaling |
Q36360699 | Increased anxiety-like behavior is associated with the metabolic syndrome in non-stressed rats |
Q51392149 | Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice. |
Q35912264 | Is the association of continuous metabolic syndrome risk score with body mass index independent of physical activity? The CASPIAN-III study. |
Q85704506 | Liuwei Dihuang, a traditional Chinese herbal formula, suppresses chronic inflammation and oxidative stress in obese rats |
Q90132767 | Maternal selenium status is profoundly involved in metabolic fetal programming by modulating insulin resistance, oxidative balance and energy homeostasis |
Q34877796 | Mechanisms of developmental programming of the metabolic syndrome and related disorders |
Q38132056 | Mediterranean diet and metabolic syndrome: an updated systematic review. |
Q37198401 | Menstrual health and the metabolic syndrome in adolescents |
Q28079375 | Metabolic Syndrome Increases the Risk for Knee Osteoarthritis: A Meta-Analysis |
Q37370043 | Metabolic syndrome and cardiometabolic risk: an update |
Q38948877 | Metabolic syndrome and dietary patterns: a systematic review and meta-analysis of observational studies. |
Q34718421 | Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. |
Q37494304 | Metabolic syndrome and polycystic ovary syndrome... and vice versa |
Q46622343 | Metabolic syndrome and selenium during gestation and lactation |
Q50884222 | Metabolic syndrome and selenium in fetal programming: gender differences. |
Q92782602 | Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review |
Q35222459 | MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes |
Q33519313 | Multivariate association analysis of the components of metabolic syndrome from the Framingham Heart Study |
Q44508882 | Mutual associations among musculoskeletal diseases and metabolic syndrome components: A 3-year follow-up of the ROAD study |
Q37149405 | Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment |
Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
Q37219583 | Nutrigenomic basis of beneficial effects of chromium(III) on obesity and diabetes |
Q51033492 | Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis. |
Q37068805 | Perturbed autonomic nervous system function in metabolic syndrome |
Q42396790 | Pharmacotherapy-Based Problems in the Management of Diabetes Mellitus: Needs Much More to be Done! |
Q37687909 | Predicting of perceived self efficacy in the amount of macronutrients intake in women with metabolic syndrome - 2012. |
Q33525176 | Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study |
Q34461330 | Prevalence of the metabolic syndrome in a rural population in Ghana |
Q37161301 | QTL-based association analyses reveal novel genes influencing pleiotropy of metabolic syndrome (MetS). |
Q37248315 | Racial differences in risk of prostate cancer associated with metabolic syndrome |
Q36948280 | Recent advances in diagnosis, treatment, and outcome of congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Q24315816 | Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue |
Q46687980 | Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: the Korea National Health and Nutrition Examination Survey (2007-2008). |
Q84979204 | Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS) |
Q39974616 | Retinal vascular caliber and metabolic syndrome in a Chinese population |
Q92267523 | The association between serum uric acid level and changes of MRI findings in knee osteoarthritis: A retrospective study (A STROBE-compliant article) |
Q51246246 | The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study. |
Q37235064 | The changing shape of type 2 diabetes |
Q54280828 | The impact of high fructose on cardiovascular system: Role of α-lipoic acid. |
Q36329919 | The metabolic syndrome: what's in a name? |
Q24657961 | Traditional chinese medicine in treatment of metabolic syndrome |
Q36982936 | Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience |
Q49910023 | Validity of triglyceride-glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study |
Q51372103 | Variation of serum monocyte chemoattractant protein-1 in patients with diabetes and metabolic syndrome. |
Q33651745 | Weight change over five-year periods and number of components of the metabolic syndrome in a Dutch cohort |
Search more.